# Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men

> **NCT06923839** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Oluf Pedersen** · enrollment: 15 (estimated)

## Conditions studied

- Healthy Male Adults

## Interventions

- **BIOLOGICAL:** Test bacterial peptide: RUCILP
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06923839
- **Lead sponsor:** Oluf Pedersen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-28
- **Primary completion:** 2025-08-27
- **Final completion:** 2026-04
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06923839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06923839, "Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT06923839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*